The ALSFRS is a scale used to assess disability in ALS patients. Dr. Feldman reported that six study patients have a stable, very slowly progressing or improved disease course at more than 700-to-approximately-850 days post-surgery. Furthermore, she stated that these patients all share two common clinical characteristics: They had no bulbar ... (more)
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuralstem-ALS-Trial-Principal-Investigator-Dr-Eva/ArticleNewsFeed/Article/detail/813642?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuralstem-ALS-Trial-Principal-Investigator-Dr-Eva/ArticleNewsFeed/Article/detail/813642?ref=25
No comments:
Post a Comment